5月29日港股通成交活跃股 | 代码 | 简称 | 类型 | 成交金额（万港元） | 成交净买入（万港元） | 日涨跌幅（%） | | --- | --- | --- | --- | --- | --- | | 03690 | 美团-W | 港股通(沪) | 483123.02 | 84224.40 | 6.62 | | 01810 | 小米集团-W | 港股通(沪) | 273168.66 | -10380.44 | -0.10 | | 06060 | 众安在线 | 港股通(沪) | 235732.61 | 61987.39 | 31.56 | | 03690 | 美团-W | 港股通(深) | 229066.00 | 20172.25 | 6.62 | | 09988 | 阿里巴巴-W | 港股通(沪) | 227089.49 | -11869.43 | 2.07 | | 00981 | 中芯国际 | 港股通(沪) | 201573.98 | -48139.37 | 1.47 | | 01810 | 小米集团-W | 港股通(深) | 196565.00 | -42607.54 | -0.10 | | 0 ...

Group 1: Top Net Buy/Sell Companies - The top net buy company is China Construction Bank (0939.HK) with a net buy amount of 38.65 billion CNY, representing a holding change of 558,592,867 shares[8] - The top net sell company is Tencent Holdings (0700.HK) with a net sell amount of -51.46 billion CNY, reflecting a holding change of -10,130,904 shares[9] Group 2: Industry Distribution of Net Buy/Sell - The financial sector shows significant net buying activity, led by China Construction Bank and China Bank, indicating strong investor confidence in financial stocks[8][9] - The technology sector, particularly Tencent and Xiaomi, experienced substantial net selling, suggesting a potential shift in investor sentiment away from tech stocks[9] Group 3: Active Stocks - Xiaomi Group (1810.HK) was the most actively traded stock with a total trading volume of 52.76 billion CNY and a net sell of -0.28 billion CNY[20] - Alibaba (9988.HK) also saw high trading activity with a total trading volume of 34.15 billion CNY and a net sell of -2.19 billion CNY[20]

Group 1 - Horizon Robotics has been included in the Hong Kong Stock Connect list, effective from May 26, which is expected to enhance its market position and attract more mainland investors [1] - The inclusion in the Stock Connect is seen as a recognition of Horizon Robotics' market status, likely increasing stock liquidity and supporting long-term development [1] Group 2 - Hong Kong Exchanges and Clearing Limited announced an increase in the position limits for Hang Seng Index derivatives, effective July 2, aiming to enhance market liquidity and solidify Hong Kong's status as a global risk management center [2] - This adjustment reflects the exchange's ongoing commitment to developing the derivatives market and is expected to attract more international investors [2] Group 3 - Haitian Flavor Industry has passed the Hong Kong Stock Exchange hearing and plans to achieve A+H listing, with significant revenue figures of approximately 25.6 billion yuan, 24.6 billion yuan, and 26.9 billion yuan for 2022, 2023, and 2024 respectively [3] - The A+H listing is anticipated to broaden Haitian's financing channels and enhance its competitiveness in the international market [3] Group 4 - Zhu Jiangtao has resigned as an executive director of China Merchants Bank due to work reasons, with Wang Xiaoqing nominated as the new executive director [4] - This management change may impact the bank's strategic direction and internal management dynamics, warranting investor attention on the new director's background and vision [4] Group 5 - On May 23, the Hang Seng Index rose by 0.24% to 23601.26, while the Hang Seng Tech Index decreased by 0.09% to 5246.87, and the Hang Seng Composite Index increased by 0.31% to 8583.86 [5]

智通财经APP获悉，2025年5月22日当天，小米集团-W(01810)、阿里巴巴-W(09988)、建设银行(00939) 位居沪港通（南向）成交额前3位，成交额分别为52.76 亿元、34.15 亿元、21.29 亿元；小米集团- W(01810)、阿里巴巴-W(09988)、小鹏汽车-W(09868) 位居深港通（南向）成交额前3位，成交额分别为 24.51 亿元、15.90 亿元、10.29 亿元。 | 公司名称 | 成交金额 | 净买入额 | | --- | --- | --- | | 小米集团-W(01810) | 24.51 亿元 | -8066.49 万元 | | 阿里巴巴-W(09988) | 15.90 亿元 | -6767.39 万元 | | 小鹏汽车-W(09868) | 10.29 亿元 | -2.89 亿元 | | 三生制药(01530) | 9.54 亿元 | -1.72 亿元 | | 腾讯控股(00700) | 8.98 亿元 | -4.02 亿元 | | 泡泡玛特(09992) | 7.78 亿元 | +2.44 亿元 | | 美团-W(03690) | 7.54 亿元 | ...

从连续性进行统计， 有2只股获南向资金连续3天以上净买入，连续净买入天数较多的有建设银行、美 团-W，连续净买入天数分别为7天、4天。以其间净买入金额统计，净买入金额最多的是建设银行，合 计净买入为55.09亿港元，其次是美团-W合计净买入为24.40亿港元。有2只股获连续净卖出，净卖出金 额居前的有腾讯控股、小米集团-W等，合计净卖出金额分别为152.32亿港元、17.32亿港元。（数据 宝） | 代码 | 简称 | 成交金额（万港元） | 成交净买入（万港元） | 今日涨跌幅（%） | | --- | --- | --- | --- | --- | | 00939 | 建设银行 | 191005.37 | 68932.56 | 0.58 | | 03690 | 美团-W | 234601.69 | 65596.17 | 0.66 | | 00883 | 中国海洋石油 | 197099.26 | 58698.23 | 1.48 | | 01093 | 石药集团 | 74160.80 | 36372.53 | 3.49 | | 01530 | 三生制药 | 228598.21 | 26829.29 | 8.7 ...

Group 1 - Southbound funds recorded a net purchase of 1.427 billion yuan today [1] - In the Hong Kong Stock Connect (Shanghai), China Construction Bank and CNOOC received net purchases of 689 million HKD and 616 million HKD respectively [1] - Alibaba-W had the highest net sell amount at 543 million HKD [1] Group 2 - In the Hong Kong Stock Connect (Shenzhen), CSPC Pharmaceutical and Pop Mart received net purchases of 364 million HKD and 139 million HKD respectively [1] - Tencent Holdings had the highest net sell amount at 792 million HKD [1]

Group 1 - The Hang Seng Index rose by 1.29%, gaining 301 points to close at 23,634 points, while the Hang Seng Technology Index increased by 1.32% and the Hang Seng Biotechnology Index surged by 4.26% [1] - Ningde Times (03750) saw a significant increase of over 16% on its first day of trading on the Hong Kong Stock Exchange [1] - 3SBio (01530) experienced a dramatic rise of 35%, nearing its historical high, following an authorization agreement with Pfizer for a PD-1/VEGF dual antibody, with Pfizer making an upfront payment of $1.25 billion and potential milestone payments up to $4.8 billion [1] Group 2 - Yiming Anke-B (01541) rose over 10% after receiving a $5 million payment from Axion Bio, indicating a promising outlook in the self-immune field for IMM0306 [2] - Basilea Pharmaceuticals-B (02616) increased by over 18% after presenting five new research results at the 2025 AACR conference [2] - Rongchang Bio (09995) rose over 14% due to the addition of new indications for Vidi Xi monoclonal antibody, with Q1 performance slightly exceeding expectations [2] Group 3 - Xiaomi Group-W (01810) increased by nearly 4% ahead of the release of multiple new products, with its self-developed SoC "Xuanjie" expected to launch soon [5] - Alibaba Pictures (01060) surged over 17%, reporting an adjusted EBITDA profit of 809 million yuan for the year, a 61% year-on-year increase [6] - Alibaba Health (00241) fell over 4% post-earnings despite a more than 62% year-on-year increase in net profit, as it did not declare a final dividend [6]

Market Overview - The Hang Seng Index rose 2.1% last week, closing at 23,345 points, marking the fifth consecutive week of gains[1] - The Hang Seng Tech Index increased by 2.0%, closing at 5,281 points[1] - Average daily trading volume increased by 16.1% week-on-week to over HKD 232.5 billion[1] - Net outflow from the Hong Kong Stock Connect was approximately HKD 8.7 billion for the week, with a significant reduction in cumulative net inflow to HKD 16.8 billion over the past 20 days[1] Sector Performance - The financial sector surged by 3.8%, driven mainly by domestic banks and insurers[1] - Industrial, energy, and telecommunications sectors also saw gains of 2% or more over the week[1] Investment Sentiment - Since mid-April, the flow of funds through the Hong Kong Stock Connect has been volatile, with a record net outflow of HKD 18.5 billion on May 12, indicating a cautious stance from southbound investors[2] - The current AH premium index has dropped to the 16.0 percentile since 2020, suggesting insufficient value for aggressive buying[2] - The Hang Seng Index faces significant resistance in the 23,500-24,000 point range, with potential for continued volatility if southbound fund support diminishes[2] Macro Dynamics - Moody's downgraded the U.S. long-term sovereign credit rating from Aaa to Aa1, citing structural debt imbalance and increasing fiscal deficit pressures[3] - The U.S. federal debt-to-GDP ratio is projected to rise from 98% in 2024 to 134% by 2035, raising concerns about long-term repayment capacity[3] - Despite the downgrade, Moody's maintains that systemic risk has not reached a critical point, and market reactions will depend more on policy responses and economic data than on the rating change itself[3] Industry Developments - The Hang Seng Healthcare Index rose by 0.6%, with notable gains from companies like CSPC Pharmaceutical (3.1% to 3.9% increase)[4] - CSPC signed an exclusive licensing agreement for a cancer treatment in the U.S., receiving an upfront payment of USD 15 million and potential milestone payments of up to USD 25 million[4] - The IPO of Heng Rui Medicine received a "subscribe" rating, with projected revenue growth of 7.3% and net profit growth of 10.1% for 2023-24[4][7] New Drug Approvals - Rongchang Biotech's new indication for its drug has been approved, expected to boost sales significantly[11] - The company reported a 59.1% year-on-year increase in revenue to RMB 530 million for Q1 2025, with a reduction in net loss by 27.2%[13] - Target price for Rongchang Biotech has been raised to HKD 45.00, reflecting positive adjustments in revenue and profit forecasts[14]

Group 1 - CICC expects companies like Mixue Group (02097) and Bruker (00325) to be included in the Hong Kong Stock Connect list following the recent adjustments to the Hang Seng Index [1] - Horizon Robotics, listed in October last year, has met the requirements for inclusion in the Hong Kong Stock Connect after being added to the Hang Seng Index in February [1] - CICC estimates that passive fund inflows for companies like ZTO Express and NetEase will be significant, with expected inflows of $128 million and $218 million respectively [1] Group 2 - The Nasdaq Golden Dragon China Index fell by 0.17%, while major US indices showed slight gains, with the Dow Jones up 0.32% [2] - Notable gains were seen in the pharmaceutical and precious metals sectors, with Novavax rising over 15% [2] - The Hang Seng Index ADR increased by 0.52%, indicating a positive sentiment in the Hong Kong market [2] Group 3 - The World Health Organization's Director-General emphasized the need for global cooperation to address unprecedented public health challenges during the 78th World Health Assembly [3] - The WHO faces a budget shortfall of $1.7 billion over the next two years, which poses a significant challenge to its global health mission [3] Group 4 - Huawei's HarmonyOS-powered personal computers were officially launched, marking a significant breakthrough for domestic operating systems in the PC sector [4] - The HarmonyOS computers support over 1,100 external device connections and have adapted over 1,000 applications [4] Group 5 - Shandong Xinhua Pharmaceutical received approval for the listing of Eicosapentaenoic Acid Ethyl Ester, marking a significant milestone in its product development [5] - The approval was granted by the National Medical Products Administration after the company submitted its application in June 2023 [5] Group 6 - Huaxing Capital announced the successful listing of its portfolio company, Weigao Blood Purification Products, on the Shanghai Stock Exchange [6] - Tian Cai Holdings is negotiating to provide instant delivery systems for major online supermarkets, enhancing its service offerings [6] Group 7 - BYD established its European headquarters in Hungary, reinforcing its commitment to long-term development in Europe [7] - The establishment of the headquarters signifies deep integration with the local automotive industry [7] Group 8 - New China Life Insurance was approved to participate in the third batch of long-term investment reform trials, aiming to enhance capital market development [8] - The company plans to establish the third phase of the Honghu Fund to facilitate long-term investments [8] Group 9 - Jianbei Miao Miao expects a significant increase of at least 50% in its annual net profit attributable to shareholders for the fiscal year ending March 31, 2025 [9] Group 10 - Leap Motor reported a revenue of 10.02 billion yuan for Q1 2025, representing a year-on-year growth of 187.1% [10] - The growth was driven by a 162.1% increase in sales volume and a 4.9% increase in revenue per vehicle [10] Group 11 - Alibaba Health reported a 13.2% increase in revenue to 30.598 billion yuan for the fiscal year ending March 31, 2025, with adjusted net profit rising by 35.6% [11] - The company achieved a profit attributable to shareholders of 1.432 billion yuan, marking a 62.14% increase [11] Group 12 - Alibaba Pictures reported a 33% increase in revenue to 6.702 billion yuan for the fiscal year ending March 31, 2025, with a net profit attributable to shareholders of 364 million yuan [12] Group 13 - Trip.com Group reported a net operating revenue of 13.8 billion yuan for Q1 2025, reflecting a 16% year-on-year increase [13] - The net profit attributable to shareholders remained stable at 4.3 billion yuan compared to the previous year [13] Group 14 - CSPC Pharmaceutical received FDA fast track designation for its CPO301 drug, aimed at treating advanced non-small cell lung cancer [14] - The drug has also been approved for clinical trials in China [14]

（来源：金石杂谈） 转自：金石杂谈 5月19日，长城基金公募研总廖瀚博火了，一起看看他的投资成绩单。 长城基金廖瀚博，硕士研究生，2012年7月至2014年6月曾就职于长城证券，20114年7月至2015年10月曾就职于海通证券，2015年10月至2017年6月曾就职 于深圳鼎诺投资，这家因经营异常在2023年年初被协会注销。 2017年6月，他正式进军公募，成为长城基金一位研究员，此后做了基金经理助理，到了2018年3月正式成为基金经理。目前他的投资经验已有7年，也成 功升职为公司研究部总经理。 截至目前，廖总管理5只基金，但业绩确实喜忧参半，更确切的说业绩并不好，两款业绩最优异的产品，一只盈利90%，一只盈利75%，但均是2018年和 2019年的产品，而且盈利90%这只你看它的C产品成立三年亏了36%；而近4年来看，他除了2023年12月接管的一只基金盈利近15%，其他三款产品全部录 得约30%的任职亏损。 | 100 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 基金代码 | 基金名称 | 相关链接 | 基金类型 ...